Lack of transmission to polymorphonuclea
β
Giuseppe Gerna; Elena Percivalle; Fausto Baldanti; Maria Grazia Revello
π
Article
π
2002
π
John Wiley and Sons
π
English
β 83 KB
## Abstract The development of a human cytomegalovirus (HCMV) vaccine for the prevention of perinatal disease is urgently needed. However, markers of HCMV attenuation are not defined at present. An in vitro model for the study of interactions of HCMVβinfected human fibroblasts and peripheral blood